Article Information
History
- August 20, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ian Tamayo1,
- Hak Joo Lee1,
- M. Imran Aslam2,
- Jian-Jun Liu3,
- Nagarjunachary Ragi1,
- Varsha Karanam2,
- Soumya Maity1,
- Afaf Saliba1,
- Esmeralda Treviño1,
- Huili Zheng3,
- Su Chi Lim3,
- Jan D. Lanzer4,
- Petter Bjornstad5,
- Katherine Tuttle6,
- Kenneth C. Bedi Jr.7,
- Kenneth B. Margulies7,
- Vasan Ramachandran2,8,
- Ahmed Abdel-Latif9,
- Julio Saez-Rodriguez4,
- Ravi Iyengar10,
- Jean C. Bopassa11 and
- Kumar Sharma1,*
- 1Center for Precision Medicine, University of Texas Health San Antonio.
- 2Division of Cardiology, University of Texas Health San Antonio.
- 3Clinical Research Unit, Khoo Teck Puat Hospital, Singapore
- 4Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany
- 5UW Medicine Diabetes Institute, University of Washington
- 6Department of Medicine, University of Washington, Seattle, WA, USA, Division of Nephrology, Department of Medicine, Kidney Research Institute, University of Washington, Seattle, Washington
- 7Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
- 8School of Public Health University of Texas Health San Antonio and University of Texas San Antonio.
- 9Department of Medicine, University of Michigan, Ann Arbor, MI
- 10Department of Pharmacological Sciences and Institute for Systems Biomedicine, Icahn School of Medicine at Mount Sinai, New York, NY
- 11Department of Cellular and Integrative Physiology, University of Texas Health San Antonio, San Antonio, Texas
- ↵*Corresponding author. Email: sharmak3{at}uthscsa.edu
Posted August 20, 2024.
Endogenous adenine is a potential driver of the cardiovascular-kidney-metabolic syndrome
